Mycoplasma Testing Market Significant Demand by 2023 | Top Companies are ABBOTT, AGILENT TECHNOLOGIES, CHARLES RIVER LABORATORIES INTERNATIONAL, EUROFINS SCIENTIFIC, F. HOFFMANN-LA ROCHE

The global mycoplasma testing market is expected to register a CAGR of 10.4% during the forecast period of 2018u20132023. North America is anticipated to dominate the market during the forecast period owing to the large number of life science research activities conducted in this region.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/17031
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Spending into R&D Activities by Bio-pharmaceutical Companies
The R&D spending by pharmaceutical companies has been steadily increasing over the past few years, both in the developed and the emerging countries. This was mainly attributed to the increased number of patent expirations, which resulted in a patent cliff in 2012 and is expected to continue for another decade. As a result of the patent expiration, most blockbuster molecules will no longer be able to generate revenue and pharmaceutical companies have no other option but to develop new revolutionary molecules for survival. Therefore, the companies are increasing their spending on R&D to accelerate the process of drug discovery and development. Mycoplasma detection and removal is critical for biologics produced for clinical studies and licensed products for human use. Thus, increase in drug discovery and development process from pharmaceutical companies is likely to augment the demand for mycoplasma testing, which will drive the global mycoplasma testing market. Additionally, increased governmental initiatives and funding in research activities, increasing demand for fast, accurate and affordable testing, and increasing cell culture contamination are further driving the market for mycoplasma testing.

Key Developments in the Market
April 2017: Thermo Fisher Scientific entered into a partnership with Australian diagnostics firm SpeeDx to obtain US Food and Drug Administration approval for its Resistance Plus MG assay for antibiotic-resistant Mycoplasma genitalium.

Major players-
ABBOTT, AGILENT TECHNOLOGIES, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., EUROFINS SCIENTIFIC, F. HOFFMANN-LA ROCHE LTD, LONZA GROUP, MERCK KGAA, PROMOCELL GMBH, SARTORIUS AG, AND THERMO FISHER SCIENTIFIC, INC., amongst others.

Request Discount on this report @ https://marketprognosis.com/discount-request/17031
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Stringent Government Regulations
Stringent government regulations are likely to hinder the mycoplasma testing market growth. The regulations implemented include the assessment of nutritive properties of the solid growth media (agar) used, the assessment of inhibitory substances in the test material, the incubation temperature ranges to be used, and the number and types of positive controls to be used. These stringent government regulations act as the major restraining factors for the market. Additionally, a high degree of consolidation for new entrants may impede the market.

North America to Dominate the Market
North America dominates the mycoplasma testing market. The factors attributing to the growth of this region are the presence of global biotech companies and pharmaceutical players and higher investment into R&D activities in the region. Asia-Pacific is anticipated to grow tremendously during the forecast period owing to factors, such as rapid research activities conducted by the pharmaceutical and biotechnology industries and the huge amount of spending in R&D activities, thereby boosting the demand for mycoplasma testingproducts.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/17031
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.